PRESS RELEASE published on 08/24/2023 at 13:00, 2 years 6 months ago Jaguar Health Engages B2i Digital to Deploy Cutting-Edge Investor Engagement Campaign
PRESS RELEASE published on 08/17/2023 at 14:30, 2 years 6 months ago Napo Pharmaceuticals, a Jaguar Health Family Company, Reports Completion of Last Patient Last Visit for its Pivotal Phase 3 OnTarget Trial of Crofelemer for Preventive Treatment of Cancer Therapy-Related Diarrhea
PRESS RELEASE published on 08/16/2023 at 14:30, 2 years 6 months ago Napo Pharmaceuticals Surveys of Neurologists, Patients, and Caregivers Regarding Amyotrophic Lateral Sclerosis (ALS) Treatment Indicate Real World Burden of Diarrhea and Potential Treatment Interruption
PRESS RELEASE published on 08/14/2023 at 14:00, 2 years 6 months ago Jaguar Health Reports Second Quarter 2023 Financial Results
PRESS RELEASE published on 08/10/2023 at 14:30, 2 years 6 months ago Jaguar Health to Hold Investor Webcast Monday, August 14th at 8:30 AM EDT Regarding Q2 2023 Financials & Corporate Updates
PRESS RELEASE published on 08/09/2023 at 14:30, 2 years 6 months ago Napo Pharmaceuticals, a Jaguar Health Family Company, Submits Funding Application to BARDA for Development of NP-300 Drug Candidate for Cholera-Related Diarrhea
PRESS RELEASE published on 08/08/2023 at 14:30, 2 years 6 months ago Napo Pharmaceuticals, a Jaguar Health Company, Announces Activation by FDA of Investigational New Drug (IND) Application for Crofelemer for Treatment of Microvillus Inclusion Disease
PRESS RELEASE published on 08/07/2023 at 14:30, 2 years 6 months ago Independent Study Published in Clinical Breast Cancer Shows Activity of Jaguar Health's Crofelemer for Neratinib-induced Diarrhea
PRESS RELEASE published on 08/03/2023 at 14:30, 2 years 6 months ago Jaguar Health to Present Aug 4th at Wall Street Wonders Investment Group Luncheon in NYC
PRESS RELEASE published on 08/02/2023 at 14:30, 2 years 6 months ago REMINDER: Napo Pharmaceuticals, a Jaguar Health Company, Supports Gay Men's Health with Participation in Pineapple Healthcare's "Butt Stuff Brunch with Dr. Carlton" August 5th
Published on 02/28/2026 at 10:00, 8 hours 3 minutes ago Storm Exploration Issues Shares to Eabametoong First Nation
Published on 02/28/2026 at 03:00, 15 hours 3 minutes ago Dynamite Blockchain Announces Change in Auditor
Published on 02/28/2026 at 02:00, 16 hours 3 minutes ago Empress Reports 2025 Year End Financial Results
Published on 02/28/2026 at 00:10, 17 hours 53 minutes ago Algo Grande Copper Closes Oversubscribed $6.52 Million Financing and Strengthens Board at AGM
Published on 02/28/2026 at 16:55, 1 hour 8 minutes ago CGTN: How China's path of democracy safeguards people's rights and interests
Published on 02/28/2026 at 11:12, 6 hours 51 minutes ago Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices
Published on 02/27/2026 at 23:00, 19 hours 3 minutes ago Biophytis increases to €2 million the ceiling of its bond facility with Hexagon Capital Fund
Published on 02/27/2026 at 18:02, 1 day ago AXA: Execution of a share repurchase agreement in relation to AXAs share buy-back program of up to Euro 1.25 billion
Published on 02/27/2026 at 17:45, 1 day ago Disclosure of Share Capital and Voting Rights Outstanding as of December 31, 2025
Published on 02/27/2026 at 17:45, 1 day ago Disclosure of Share Capital and Voting Rights Outstanding as of January 31, 2026
Published on 02/27/2026 at 08:45, 1 day 9 hours ago Air Liquide and Holcim sign an agreement to decarbonize cement production with a carbon capture project in Belgium
